
Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience
Kuo, Christopher, Kent, Paul M., Logan, Antonio D., Tamulonis, Karen B., Dalton, Kristen L., Batus, Marta, Fernandez, Karen, Mcfall, Rebecca E.Volume:
64
Langue:
english
Journal:
Pediatric Blood & Cancer
DOI:
10.1002/pbc.26265
Date:
April, 2017
Fichier:
PDF, 362 KB
english, 2017